Research Article Details

Article ID: A01658
PMID: 34664321
Source: J Clin Lab Anal
Title: Association between apolipoprotein E gene polymorphism and nonalcoholic fatty liver disease in Southern China: A case-control study.
Abstract: BACKGROUND: Apolipoprotein E (ApoE) polymorphisms have been reported to be associated with nonalcoholic fatty liver disease (NAFLD), but the conclusions of studies are inconsistent in different regions. The present study aims to investigate the role of ApoE genotypes on NAFLD in southern China. METHODS: A total of 1064 subjects including 372 NAFLD patients and 692 controls who attended Meizhou People's Hospital located in southern China from March 1, 2016 to April 30, 2020 were enrolled in this study. The ApoE genotypes were detected and the laboratory parameters were examined. RESULTS: Significant differences were observed between NAFLD patients and controls in the prevalence of &#949;3/&#949;3 (p&#160;<&#160;0.001) and &#949;3/&#949;4 (p&#160;=&#160;0.004). NAFLD patients presented higher frequency of &#949;4 allele than controls (p&#160;=&#160;0.013). Logistic regression analysis suggested that &#949;3/&#949;3 was an independent risk factor (OR: 1.435, 95% CI: 1.084-1.891, p&#160;=&#160;0.010), while &#949;3/&#949;4 was an independent protective factor (OR: 0.578, 95% CI: 0.404-0.828, p&#160;=&#160;0.003) for development of NAFLD. In addition, allele &#949;4 showed a protective effect on NAFLD with an adjusted OR of 0.588 (95% CI: 0.420-0.824, p&#160;=&#160;0.002). CONCLUSION: Our results suggested that ApoE genotype was associated with the development of NAFLD in the population of southern China. Individuals carrying &#949;3/&#949;3 were at higher risk of NAFLD, while those carrying &#949;3/&#949;4 were at lower risk of NAFLD.
DOI: 10.1002/jcla.24061